A Study of Lenvatinib in Pediatric Participants With Relapsed or Refractory Solid Malignancies
The main purpose of this study is to evaluate the antitumor activity and safety of Lenvatinib (MK-7902/E7080) in children, adolescents, and young adults with relapsed or refractory solid malignancies after administration.